Guardant Health director sells 10,000 shares after option exercise
Guardant Health, Inc. director Meghan V. Joyce reported option exercises and related share sales.
Rhea-AI Filing Summary
Guardant Health, Inc. director Meghan V. Joyce reported option exercises and related share sales. On June 3, 2026, she exercised stock options to acquire a total of 10,000 shares of Guardant Health common stock at exercise prices of $38.005 and $38.420 per share.
On the same date, she executed open-market sales totaling 10,000 shares of common stock in multiple price tranches, at weighted average prices reported around the high $120s per share. Following these transactions, she directly holds 11,183 shares of Guardant Health common stock, and the exercised option positions have been fully converted into shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 10,000 shares ($889K approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
Joyce Meghan V.
Role
Director
Sold
10,000 shs ($1.27M)
Approx. gross sale proceeds
$1.27M
Approx. exercise cost
$381K
Approx. pre-tax spread
$889K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 1,197 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) | 8,803 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,197 | $38.42 | $46K |
| Exercise | Common Stock | 8,803 | $38.005 | $335K |
| Sale | Common Stock | 3,516 | $126.5157 | $445K |
| Sale | Common Stock | 5,728 | $127.1054 | $728K |
| Sale | Common Stock | 650 | $128.0196 | $83K |
| Sale | Common Stock | 106 | $129.3111 | $14K |
Holdings After Transaction:
Stock Option (Right to Buy) — 7,908 contracts (Direct);
Common Stock — 11,183 shares (Direct)
Footnotes (6)
- F1. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.80 to $126.785. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $126.815 to $127.75. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F3. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $127.92 to $128.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $129.28 to $129.83. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5. The stock option award vested in full on June 14, 2023.
- F6. The stock option award vested in full on June 12, 2024.
Key Figures
Shares sold: 10,000 shares
Shares exercised: 10,000 shares
Exercise price (primary option): $38.005/share
+5 more
8 metrics
Shares sold
10,000 shares
Total Guardant Health common shares sold on June 3, 2026
Shares exercised
10,000 shares
Total shares acquired via stock option exercises on June 3, 2026
Exercise price (primary option)
$38.005/share
Stock option covering 8,803 underlying Guardant Health shares
Exercise price (secondary option)
$38.420/share
Stock option covering 1,197 underlying Guardant Health shares
Shares held after transactions
11,183 shares
Direct Guardant Health common stock ownership following June 3, 2026 trades
Sale price example
$126.5157/share
One reported weighted average sale price tranche on June 3, 2026
Highest reported sale range
$129.28–$129.83
Footnote F4 price range for part of the 10,000 shares sold
Option expiration dates
2032-06-14 & 2033-06-14
Expiration for the exercised stock option awards
Key Terms
open-market sale, Stock Option (Right to Buy), weighted average sales price per share, derivative security, +1 more
5 terms
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Guardant Health (GH) director Meghan V. Joyce report in this Form 4?
Director Meghan V. Joyce reported exercising stock options for 10,000 Guardant Health shares and selling 10,000 shares in open-market transactions on June 3, 2026, leaving her with 11,183 directly held common shares afterward.
How many Guardant Health (GH) stock options did Meghan V. Joyce exercise?
She exercised options covering 10,000 Guardant Health shares, split into 8,803 shares at a $38.005 exercise price and 1,197 shares at a $38.420 exercise price, converting these derivative positions into common stock on June 3, 2026.
Were the Guardant Health (GH) stock sales done in a single trade or multiple trades?
The reported sales were executed in multiple transactions. Footnotes explain that each weighted average sale price reflects numerous trades within specified price ranges, and full trade-by-trade details are available from the reporting person upon request.
What do the footnotes say about Meghan V. Joyce’s Guardant Health (GH) option grants?
Footnotes indicate the exercised stock option awards had vested in full by June 14, 2023 and June 12, 2024, meaning the options were fully vested before their June 3, 2026 exercise into Guardant Health common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
